News

The provision calls for regulators to help makers free safe drugs from prescription requirements.

Forty-three percent of reviewed hospitals are posting fewer prices now than in the November 2024 report.

"This is more than just policy talk -- it's the kind of change that could disrupt the entire health care ecosystem," said Eric Crites, senior vice president of enterprise partnerships at Q-Centrix.

Workers with mental health conditions are twice as likely as those without to report unmet mental health needs.

Anthem Blue's parent maintains in the complaint that underwriting expertise is crucial to its competitive edge.

Employer costs for GLP-1 agonists and similar drugs could end up averaging $3.17 to $22.88 per enrollee per month.